Skip to content
FIND A HEALTH VALLEY ACTOR

Interview Sacha Sidjanski

Dr. Sacha Pierre Sidjanski

Dr. Sacha Pierre Sidjanski is in charge of External Relations at the Faculty of Life Sciences at EPFL. He explains why the Life Sciences sector is booming in Switzerland and why the country will stay a big player in the field.     ✅ A dense academic network with strong state support ✅ Researchers and…

Read More

🔺4à6 BioAlps at Incyte🔺

BioAlps Incyte

  On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges.   About 70 people participated at the BioAlps 4à6 event at Incyte, and had the opportunity to listen to: Ela Zawislak, Head of Public Affairs, Incyte EuropeHead of Public Affairs, Incyte Europe Incyte Ekaterine Asatiani, Division…

Read More

Novochizol SA and Alpha Chitin Partner to Produce a Chitosan-Based Polysaccharide

Novochizol Alpha Chitin

Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products.   Alpha Chitin, a French biobased chemistry company (Lacq – Aquitaine) and producer of innovative high-quality chitosans, and Novochizol SA, a Swiss biotech (Monthey – Valais) with a unique chitosan processing technology, today announced the creation of a joint venture to realize the…

Read More

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

Sofia Genetics Microsft

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure   SOPHiA GENETICS™ (Nasdaq: SOPH), a cloud-native software company in the healthcare sector based in Lausanne (Switzerland), is embarking on a multi-year integrated strategic partnership with Microsoft to improve healthcare workflows globally. This investment in…

Read More

Dixi Polytool wins CSEM’s Digital Journey Contest

CSEM Dixi Polytool

The company will receive CHF 100,000 in technical support from CSEM to develop a smart factory and a 100% autonomous production chain.   Family-owned DIXI Polytool is based in the heart of Switzerland’s watchmaking county, Le Locle in Neuchâtel. Specializing in precision, solid carbide, and diamond cutting tools, the company plans to use CSEM’s knowledge…

Read More

Interview Prof. Yogeshvar Kalia

Prof Kalia

Prof. Yogeshvar Kalia is Professor at the Faculty of Pharmaceutical Sciences at the University of Geneva (UNIGE) speaks about the necessity to create more bridges between the Academic World and the Industry.   ✅ Collaboration between academic institutions and industries is key ✅ DeepTech and discoveries are done in Universities, Big Pharma companies focus drug…

Read More

How does the microbiota work?

Microbiome

Researchers at the University of Bern and University Hospital Bern have been able to comprehensively study the bacteria of the small intestine. The findings contribute to a better understanding of intestinal diseases such as Crohn’s disease or celiac disease and to the development of new therapeutic approaches.   Humans have just as many microbes in…

Read More

A new test to avoid miscarriages and strokes

HUG Endotelix

The HUG and the Unige have found a way to better detect the antibodies that cause thrombosis, which leads to strokes and heart attacks, in young and pregnant women.   At least 15% of miscarriages are due to an autoimmune disease called antiphospholipid syndrome. It affects between 1 and 5% of the world population. And…

Read More

Debiopharm invests in Digital Health

Debiopharm Investment Fund

Debiopharm’s strategic corporate fund invests in digital health, smart data & innovative tech start-ups   The fund typically invests in Serie A and B rounds, between CHF 3 to 5 million.    Smart Data Companies that leverage medical data and AI to have an impact on either the patient journey or the development of pharmaceutical…

Read More

Cordis spends 1.14 billion francs to buy MedAlliance

MedAlliance

Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis for 1.14 billion francs.   Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of $35M and upfront closing payment of…

Read More